Cargando…
Inflammatory cytokines and alpha-fetoprotein concentrations for predicting survival in patients with hepatocellular carcinoma
BACKGROUND: Chronic inflammation is crucial in the evolution of hepatocellular carcinoma (HCC). Circulatory and intratumoral inflammatory factors are always increased in these patients. In this study, we determined the value of pretherapy serum concentrations of several inflammatory cytokines for pr...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
AME Publishing Company
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8798832/ https://www.ncbi.nlm.nih.gov/pubmed/35116917 http://dx.doi.org/10.21037/tcr.2019.08.09 |
_version_ | 1784641910553444352 |
---|---|
author | Han, Xue Gu, Yangkui Li, Shaolong Chen, Minshan Cai, Qingqing Huang, Jinhua |
author_facet | Han, Xue Gu, Yangkui Li, Shaolong Chen, Minshan Cai, Qingqing Huang, Jinhua |
author_sort | Han, Xue |
collection | PubMed |
description | BACKGROUND: Chronic inflammation is crucial in the evolution of hepatocellular carcinoma (HCC). Circulatory and intratumoral inflammatory factors are always increased in these patients. In this study, we determined the value of pretherapy serum concentrations of several inflammatory cytokines for predicting survival among patients with HCC. METHODS: We retrospectively analyzed data of 85 patients with HCC with known alpha-fetoprotein (AFP) concentrations diagnosed at our institute. Before therapy, serum concentrations of interleukin (IL)-2, -4, -6, -10, interferon gamma, and tumor necrosis factor alpha were measured by flow cytometry. Correlations between these serum factors and clinical parameters were tested. Statistical analysis was made by using non-parametric procedures and survival analysis. The expression of IL-6 and the co-expression of IL-6 and CD11b, marker of myeloid cell in HCC tumor tissues, were evaluated by immunohistochemistry and immunofluorescence, respectively. RESULTS: The only independent predictor of overall survival (OS) was IL-6 [hazard ratio (HR), 3.338; 95% CI, 1.671 to 6.666; P=0.001]. OS was shorter among patients with high concentrations of both IL-6 (≥1.435 pg/mL) and AFP (≥400 ng/mL) than it was in those with high concentrations of either IL-6 or AFP; survival was significantly longer in patients with low concentrations of both markers (P<0.001). Immunostaining showed that IL-6 expression was localized to the stroma of the tumor and was co-expressed with CD11b positive cells. CONCLUSIONS: The combination of serum concentrations of IL-6 and AFP more accurately predicts survival in HCC patients. |
format | Online Article Text |
id | pubmed-8798832 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2019 |
publisher | AME Publishing Company |
record_format | MEDLINE/PubMed |
spelling | pubmed-87988322022-02-02 Inflammatory cytokines and alpha-fetoprotein concentrations for predicting survival in patients with hepatocellular carcinoma Han, Xue Gu, Yangkui Li, Shaolong Chen, Minshan Cai, Qingqing Huang, Jinhua Transl Cancer Res Original Article BACKGROUND: Chronic inflammation is crucial in the evolution of hepatocellular carcinoma (HCC). Circulatory and intratumoral inflammatory factors are always increased in these patients. In this study, we determined the value of pretherapy serum concentrations of several inflammatory cytokines for predicting survival among patients with HCC. METHODS: We retrospectively analyzed data of 85 patients with HCC with known alpha-fetoprotein (AFP) concentrations diagnosed at our institute. Before therapy, serum concentrations of interleukin (IL)-2, -4, -6, -10, interferon gamma, and tumor necrosis factor alpha were measured by flow cytometry. Correlations between these serum factors and clinical parameters were tested. Statistical analysis was made by using non-parametric procedures and survival analysis. The expression of IL-6 and the co-expression of IL-6 and CD11b, marker of myeloid cell in HCC tumor tissues, were evaluated by immunohistochemistry and immunofluorescence, respectively. RESULTS: The only independent predictor of overall survival (OS) was IL-6 [hazard ratio (HR), 3.338; 95% CI, 1.671 to 6.666; P=0.001]. OS was shorter among patients with high concentrations of both IL-6 (≥1.435 pg/mL) and AFP (≥400 ng/mL) than it was in those with high concentrations of either IL-6 or AFP; survival was significantly longer in patients with low concentrations of both markers (P<0.001). Immunostaining showed that IL-6 expression was localized to the stroma of the tumor and was co-expressed with CD11b positive cells. CONCLUSIONS: The combination of serum concentrations of IL-6 and AFP more accurately predicts survival in HCC patients. AME Publishing Company 2019-09 /pmc/articles/PMC8798832/ /pubmed/35116917 http://dx.doi.org/10.21037/tcr.2019.08.09 Text en 2019 Translational Cancer Research. All rights reserved. https://creativecommons.org/licenses/by-nc-nd/4.0/Open Access Statement: This is an Open Access article distributed in accordance with the Creative Commons Attribution-NonCommercial-NoDerivs 4.0 International License (CC BY-NC-ND 4.0), which permits the non-commercial replication and distribution of the article with the strict proviso that no changes or edits are made and the original work is properly cited (including links to both the formal publication through the relevant DOI and the license). See: https://creativecommons.org/licenses/by-nc-nd/4.0/. |
spellingShingle | Original Article Han, Xue Gu, Yangkui Li, Shaolong Chen, Minshan Cai, Qingqing Huang, Jinhua Inflammatory cytokines and alpha-fetoprotein concentrations for predicting survival in patients with hepatocellular carcinoma |
title | Inflammatory cytokines and alpha-fetoprotein concentrations for predicting survival in patients with hepatocellular carcinoma |
title_full | Inflammatory cytokines and alpha-fetoprotein concentrations for predicting survival in patients with hepatocellular carcinoma |
title_fullStr | Inflammatory cytokines and alpha-fetoprotein concentrations for predicting survival in patients with hepatocellular carcinoma |
title_full_unstemmed | Inflammatory cytokines and alpha-fetoprotein concentrations for predicting survival in patients with hepatocellular carcinoma |
title_short | Inflammatory cytokines and alpha-fetoprotein concentrations for predicting survival in patients with hepatocellular carcinoma |
title_sort | inflammatory cytokines and alpha-fetoprotein concentrations for predicting survival in patients with hepatocellular carcinoma |
topic | Original Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8798832/ https://www.ncbi.nlm.nih.gov/pubmed/35116917 http://dx.doi.org/10.21037/tcr.2019.08.09 |
work_keys_str_mv | AT hanxue inflammatorycytokinesandalphafetoproteinconcentrationsforpredictingsurvivalinpatientswithhepatocellularcarcinoma AT guyangkui inflammatorycytokinesandalphafetoproteinconcentrationsforpredictingsurvivalinpatientswithhepatocellularcarcinoma AT lishaolong inflammatorycytokinesandalphafetoproteinconcentrationsforpredictingsurvivalinpatientswithhepatocellularcarcinoma AT chenminshan inflammatorycytokinesandalphafetoproteinconcentrationsforpredictingsurvivalinpatientswithhepatocellularcarcinoma AT caiqingqing inflammatorycytokinesandalphafetoproteinconcentrationsforpredictingsurvivalinpatientswithhepatocellularcarcinoma AT huangjinhua inflammatorycytokinesandalphafetoproteinconcentrationsforpredictingsurvivalinpatientswithhepatocellularcarcinoma |